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Abstract
Objectives Intrathecal drug administration using an implanted
pump system is well established in intractable spasticity
and pain. However, despite continuous advancements in
manufacturing technology, adverse events related to the pump
and catheter still occur. Most of them, such as migration,
damage, disconnection and occlusion, are related to the spinal
catheter. The aim of this overview is to update radiologists on
how plain radiography of the implanted delivery system for
intrathecal drug administration should be interpreted and to
increase awareness for the need of urgent and timely multidis-
ciplinary troubleshooting.
Methods Plain radiographic images of patients treated with
intrathecal drug administration using an implantable drug
delivery system were analysed in a multidisciplinary setting
at our (university) referral centre for complications in intrathe-
cal drug administration.
Results Examples of catheter-related adverse events are
described and a proposal is made for stepwise interpretation
of standard plain radiographic images.
Conclusions Plain radiological images are the mainstay for
the diagnosis of catheter-related adverse events in intrathecal
drug delivery. Radiologists play an important role in an early
diagnosis. An awareness of abnormal radiological findings
seems important to avoid a life-threatening withdrawal
syndrome.
Teaching points
•Untimely cessation of intrathecal drug delivery can lead to a
life-threatening withdrawal syndrome.
• Initially mild symptoms can lead to an exacerbation of a
withdrawal syndrome.
• Most intrathecal catheter-related problems are visible on
plain radiography.
• Common causes of catheter problems are migration, lacer-
ations, occlusion and disconnection.
• Knowledge on implanted intrathecal catheters is crucial for
interpretation of plain radiography.
Keywords Radiography . Diagnostic imaging . Spinal
infusions . Implantable infusion pumps . Adverse events
Introduction
For over 30 years intrathecal drug delivery systems have been
successfully applied in thousands of patients for the manage-
ment of spasticity [1, 2] and dystonia (both intrathecal baclo-
fen) [3], and for chronic pain (intrathecal analgesic drugs) [4,
5]. Compared with oral administration, infusion directly into
the cerebrospinal fluid (CSF) has an extended treatment effect
and with fewer unwanted side effects [1, 6]. There is general
consensus that intrathecal therapy should be reserved for
patients who have an insufficient response to more conserva-
tive therapies and/or for patients who experience serious side
effects [7].
Despite generally favourable and safe outcomes [8, 9] and
continuous advancements in manufacturing technology, pump
and catheter-related adverse events still occur [10]. Although
the benefits usually outweigh the risks [11], even limited
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exposure to adverse events remains a problem. Early recogni-
tion of complications and their prompt management is needed.
Most of the drug delivery device-related adverse events
are caused by intrathecal catheter failure [12–14].
Approximately 15–40% of patients experienced catheter
complications [2, 15–18]. With the newly developed
Ascenda catheter instead of the older silicone catheters,
a tremendous reduction from 18 to 1.1% was reported by
Motta and Antonello [19]. The main reasons for this are
migration, lacerations, occlusion and disconnection of the
catheter, which cause a sudden cessation of intrathecal
drug administration. Abrupt interruption of intrathecal
Fig. 1 Implanted, programmable
pump system. External view (a)
and drawing of implanted pump
and intrathecal catheter 8731SC
(b). Pumpwith the catheter access
port (black arrowhead), pump
catheter connection (thick black
arrow), refill membrane (thick
white arrow) and suture loops for
fixation (thin grey arrow),
catheter-catheter segment
connection (thin white arrow) and
titanium catheter end (grey
arrowhead)
Fig. 2 Anterior-posterior (a) and lateral (b) plain radiography of the
lumbar spine, in vivo image (d) and artist rendering (c) of the typical
folded fixation anchor (with anchor symbol), large diameter catheter
pump segment (black arrow), small diameter outside spinal canal (thick
white arrow) and intrathecal (small white arrow, catheter end symbol)
segment of the 8731SC catheter
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baclofen delivery can present within several to 48 h with
a spectrum of signs and symptoms. Then, the initially
mild symptoms of exacerbation of spasticity, fever,
excessive sweating and pruritus can escalate to a
life-threatening multi-organ failure. Over time, hyperther-
mia develops with values up to 42° C [20], accompanied
by nausea, respiratory distress, hypotension, tachycardia,
hallucinations, delirium, disorientation, psychosis, some-
times with seizures, rhabdomyolysis with increased creat-
inine kinase levels resulting in disseminated intravascular
coagulation and multi-organ failure [13, 21–29]. In rare
cases, intrathecal baclofen withdrawal can even be fatal
[30, 31]. The symptoms are probably related to the re-
lease of excitatory neurotransmitters that occurs when
baclofen-mediated inhibition GABA-B effect is abruptly
interrupted [32–34]. The heterogeneous symptoms occur-
ring during withdrawal of intrathecal baclofen and of in-
trathecal opioid treatment may result in misdiagnosis,
wrong referrals and (eventually) in a disastrous treatment
delay. An additional problem is the referral of the patient
in good time to a specialised centre, which is a requisite
for successful treatment [33]. Different imaging tech-
niques, including plain radiography, fluoroscopy with
Table 1 Explanation of the symbols
Fig. 3 Anterior-posterior (a) and lateral (b) plain radiography of the
lumbar spine, in vivo image (d) and artist rendering (c) of the typical
unfolded fixation anchor of the Ascenda catheter. The small diameter
catheter pump is hardly visible. The only reference points (a, b) are the
needle connector (needle symbol), the unfolded anchor (anchor symbol),
and the titanium catheter tip (catheter end symbol)
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contrast material injection via the access port of the
pump, CT myelography, MRI and 111In-DTPA scintigra-
phy, are used to diagnose malfunction of the drug deliv-
ery system [14, 36–41]. Of all these imaging modalities,
plain radiography is the most important, especially in an
acute situation. Furthermore, a rigorous and adequate in-
terpretation of the images by the radiologist is crucial to
make a correct diagnosis and, if necessary, implement
(urgent) interventions.
This overview aims to offer the radiologist a systematic
approach for the evaluation of all parts of the intrathecal de-
livery system on plain radiography. This may help radiologists
to identify causes of drug delivery failures in emergency and
in chronic situations.
Materials and methods
Below, we describe the most commonly used methods: (1)
intrathecal drug delivery system, (2) intrathecal catheter and
(3) surgical implantation technique.
Intrathecal drug delivery system
Although several pump systems are available, the implant-
able Synchromed II pump (Medtronic, Minneapolis, MN,
USA) is by far the most rigorously tested and most applied
implanted programmable device, worldwide (Fig. 1). Here,
we focus on this pump only.
The implantable Synchromed II pump and the related
intrathecal catheters have received the Conformité
Européenne (CE) mark and are approved by the U.S.
Food and Drug Administration (FDA) for treatment of
pain and spasticity. During continuous intrathecal drug
delivery, the prescribed medication is administered
through an intrathecal catheter, connected with an
implantable programmable pump system. The pump pro-
vides precise intrathecal drug delivery to patients with
spasticity or chronic intractable pain. Via the refill sep-
tum, which is in the centre of the device (Fig. 1a), the
reservoir is filled percutaneously. The gas below the res-
ervoir exerts pressure which advances the drug into the
inner tubing of the pump. The accompanying programmer
device enables the delivery rate and mode to be pro-
grammed. A rotor system pushes the programmed dose
Fig. 4 Reel syndrome with signs
of withdrawal syndrome in a
52-year-old woman with dystonia
in CRPS. The apex of the pump is
turned from the 11 o’clock to 2
o’clock position (white arrow).
Because of the visible traction on
the catheter (black arrow), the
pump must be rotated several
times about the horizontal axis
Fig. 5 Disconnection at the pump-catheter site (white arrow) with signs
of withdrawal syndrome in a 52-year-old woman with dystonia in
complex regional pain syndrome
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with precision through the catheter access port via the
catheter into the intrathecal space.
Intrathecal catheter
Over time, several catheter types for the implantable
Synchromed II pump have been developed and are
commercially available. Although two types of intrathecal
catheters (the 8731SC, and the Ascenda) are currently avail-
able, older types are still in use. Determining the type of im-
planted catheter via plain radiography is important for correct
interpretation.
The 8731SC catheter is normally visible on plain ra-
diography (Fig. 2; see Table 1 for a key to the symbols
Fig. 6 Reel syndrome with signs of withdrawal syndrome in a 45-year-
old extremely obese womanwith spasticity in multiple sclerosis. Baseline
plain radiography (a, c, e) with follow-up images after 4 weeks (b, d, f).
The apex of the pump is turned from the 11 o’clock (a) to the 2 o’clock
(b) position (black-white arrow). The Ascenda needle connector is moved
from the original position (a) to a more lateral position (b) (grey-white
arrow) with disconnection of catheter pump segment (black arrow). The
Ascenda catheter is hardly visible (white arrows). The tip of the catheter is
unchanged (c–f) at level T8 (grey-black arrow)
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used in the figures). The pump-catheter connection is
sutureless and the two segments of the catheter have a
different diameter, i.e. the pump segment of the catheter
has a larger outer diameter than the spinal segment.
Furthermore, the 8731SC catheter is provided with a
two-pin catheter-catheter connector, a folded V-wing an-
chor which is fixed on the fascia, and has a catheter-end
with six side holes and a round titanium tip. The folded
V-wing in the 8731SC catheter locks the catheter in
place (Fig. 2c, d) and is, therefore, important for the
Fig. 8 Twiddler’s syndrome with signs of withdrawal syndrome in a 51-
year-old woman with dystonia in complex regional pain syndrome. A
repeatedly twisted old type catheter is visible on lateral plain radiography
behind the implanted pump (white arrow) (a), magnification of the pump
with artist rendering (b) and an in vivo image (c). The catheter is fixed to
the pump with an old sutured connector (grey arrow)
Fig. 7 A magnification view of
the black circle (a) shows the
radiopaque pump identifier
consisting of the logo of the
manufacturer and three alphabetic
letters (white arrow) with visible
electronics (b) into the left-hand
side (black arrow). For (some)
odd rotations of the pump to the
vertical axis (Twiddler’s syn-
drome), the pump is located on
the head, which can be recognised
by the logo in mirror image, and
the electronics to the right-hand
side (c)
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diagnosis of catheter disorders. A partially or completely
unfolded anchor (see Fig. 9) creates a major risk
for dislodgement, potentially leading to a complete
migration.
The Ascenda catheter (Fig. 3) has a poor opacity and the
pump-catheter connection is also sutureless. Both catheter
segments have the same diameter and are connected to each
other with a needle connector. The fixation on the fascia is
conducted by an unfolded V-wing anchor (Fig. 3c, d). This
catheter also has a catheter-end with six side holes and a
round titanium tip. In contrast to the 8731SC catheter, the
unfolded V-wing in the Ascenda catheter locks the catheter
in place.
Older catheters have a sutured pump-catheter connec-
tion and distinct differences in anchoring (this could even
be absent), different catheter-catheter connection, different
catheter ends, and the presence or absence of a mushroom-
shaped titanium tip. Either a so-called ‘one’ piece catheter
type with only a connection at the pump or a two-segment
catheter are used.
Surgical implantation technique drug delivery system
Implantation is performed under local anaesthesia with in-
travenous sedation or general anaesthesia, With the patient
in lateral decubitus position, a 3– to 4-cm dorsal midline
incision is made at the planned implantation level up to the
muscular fascia. On level L2-L3 or L1-L2 a silicone cath-
eter is obliquely inserted into the intrathecal space, using a
15-G (8731SC catheter) or 16-G (Ascenda catheter) intro-
duction (Tuohy) needle. The introduction needle is
inserted 1–2 cm using a paramedian approach [42] to pre-
vent catheter shearing and crushing by the frequent move-
ments of the vertebral spinal process when a midline
Fig. 10 Sheared catheter 8731SC
(gray arrow) with retracted
segment partially outside the
spinal canal, with no
cerebrospinal leakage and no
clinical signs of postural spinal
headache or an intracranial
hypotension syndrome, in a 48-
year-old woman with cerebral
palsy treated with intrathecal
baclofen
Fig. 9 Catheter 8731SC migration (gray arrow) caused by an open V-
wing anchor (anchor symbol) in an 80-year-old woman with intractable
pain and spasticity caused by failed back surgery syndrome, with a spinal
cord lesion (SCL) T12 treated with intrathecal baclofen
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approach is applied. Under fluoroscopy the catheter is ad-
vanced to the mid-thoracic level [43–45]. Some physicians
claim that positioning of the tip at the high thoracic, or
even cervical position, gives a better result on the upper
extremities; however, this has not yet been proved [46,
47]. At the abdominal site, a subcutaneous pocket is made
in which the pump is placed and sutured using the outside
suture loops of the pump. The pump catheter segment is
connected suturelessly to the pump and tunnelled from the
pump pocket to the dorsal incision, where it is connected
to the spinal catheter part. The excess catheter length
should be placed dorsal to the pump in the pocket.
Radiological examination after implantation of an
intrathecal drug delivery system
Since the quality of the perioperative fluoroscopic images
is insufficient for detailed information, routine postopera-
tive plain radiography is performed after all of the surgi-
cal procedures and manipulations. For adequate interpre-
tation, plain radiography of the pump and the entire im-
planted catheter in two directions is required [36].
Development of a stepwise interpretation schedule
A stepwise interpretation of the standard plain radiograph-
ic images has been developed (Appendix) to offer the
radiologist a systematic approach for the evaluation of
all parts of the intrathecal delivery system on plain radi-
ography. This stepwise interpretation is based on expert
opinion.
Results
The normal and abnormal plain radiographic findings are de-
scribed in a 14-step approach, a pump roller examination is
also described.
Fourteen-step interpretation of standard plain
radiographic images
Step 1 Previous radiographs available?
Comparison with previous radiological examinations is
required to detect subtle or overt changes in the location
and position of the pump and catheter.
Step 2 Type of catheter used.
Primarily the use of a 8731SC catheter (Figs. 1a, 2, 5,
9, 10, 11), an Ascenda catheter (Figs. 3 and 6) or an
older one (Figs. 4 and 8) should be determined.
Step 3 Pump position
The position of the pump is described by reporting
the pump apex (Figs. 1a, 3, 4, 5, 6, 7, 9, 10, and 12) as
a location on the clock face and the abdominal quadrant
in which the pump is placed. To exclude pump rota-
tions, it is important to compare the current pump po-
sition with previous radiological images. Rotations
about the horizontal axis are known as the Reel syn-
drome [48, 49] (Figs. 4 and 6), resulting in traction
Fig. 11 A 62-year-old man with treatment-resistant spasticity was suc-
cessfully treated for many years with intrathecal baclofen. During exac-
erbation of the clinical symptomatology, the catheter 8731SC was found
to be torn off and left behind in the spinal canal (white arrow). For further
treatment, a new catheter, of the same type was inserted (gray arrow)
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on the catheter and risk of disconnection at the level of
the pump-catheter (Fig. 5) or catheter-catheter connec-
tion (Fig. 6b).
Step 4 Pump-catheter connection
On plain radiography, the pump-catheter connection is
clearly visible (Figs. 2, 3, 4, 5, and 9).
Step 5 Excess pump catheter segment behind the pump
In common practice, the excess catheter length is po-
sitioned behind the pump. In case the catheter surplus is
located above the pump reservoir, refilling with medica-
tion or injecting contrast material in the catheter access
port might result in catheter puncturing. Catheter perfo-
ration can result in dose adjustment problems, or even in
a severe withdrawal syndrome [38].
Step 6 Control identifier
With the magnification view the radiopaque identifier
with the company logo and three alphabetic letters can be
recognised opposite the pump apex (Fig. 7). When the
pump is rotated around its longitudinal axis an odd num-
ber of times, the identifier is visible as a mirror image.
This rotation was originally described in cardiac pace-
makers [50] and is known as Twiddler’s syndrome. The
rotation can occur either spontaneously or as result of
repeated twiddling with the device by the patient. The
syndrome has also been described in an implanted pump
for intrathecal drug administration [51]. After several ro-
tations (Fig. 10), the catheter will occlude, rupture or dis-
lodge resulting in termination of the drug delivery.
Step 7 Catheter pump segment
The 8731SC thick-walled pump catheter segment is clearly
visible (Figs. 1a, 2, 5 and 10) and in most cases the spinal
segment is also visible (Figs. 2, 9, 10 and 11) The lack of
opacity of the Ascenda catheter creates problems with visual-
isation of the pump segment (Figs. 5 and 6). Normally, this
segment is clearly visible in older catheters.
Step 8 Catheter-catheter connector
The standard position of the clearly visible catheter-
catheter connector is near the spine (Figs. 3, 4, 6b and
10). However, if the connection is placed in the pump
pocket, recognition can be difficult. In the 8731SC cath-
eter, the connector is visible as a two-pin connector
(Fig. 10), in the Ascenda catheter as a needle (Figs 3
and 8a,b,e), and in older catheters often as a sharp
small two-pin connector.
Step 9 Spinal segment of the catheter outside the spinal canal
The spinal segment of the 8731SC catheter has a
smaller diameter than the pump segment and seems to
be vulnerable to twisting, migration (Fig. 9) and shear-
ing (Fig. 10). The pump segment and the spinal seg-
ment of the Ascenda catheter have the same small
Fig. 12 In this pump rotor examination, a normal rotation was found (change in position indicated by the black arrows). The white arrows show the
pump position identifier (Fig. 7)
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diameter. The improved mechanical properties make it
less vulnerable. Kinking cannot be demonstrated on
plain radiography in all implanted catheters. For a def-
inite conclusion, additional investigations, such as injec-
tion of contrast material or scintigraphy, are needed.
Step 10 Different anchors
A folded anchor in the 8731SC catheter (Fig. 2) and an
unfolded anchor in the Ascenda catheter (Fig. 3) are pres-
ent. In older catheters, both folded and unfolded anchors
can be found. At the anterior-posterior view, anchors are
often poorly visible (Fig. 3a); whereas on the lateral im-
age they are adequately visible (Fig. 3b).
Step 11 Catheter insertion, midline or paramedian?
Inserting an intrathecal catheter using the midline ap-
proach raises the risk of catheter crushing due to spinal
column movements (Fig. 10). Therefore, a paramedian
approach is the standard implantation technique.
Steps 12–13 Spinal intrathecal catheter segment
Due to the poor visibility of the Ascenda catheter, the
thoracic or the cervical vertebral column catheter segment
is inadequately imaged. This leads to lack of information
on the position of the catheter.
Due to the titanium end, the radiopaque tip can be
recognised (Figs. 3 and 6). Attention must be paid to
retained catheter fragments (Fig. 11). This can occur at
the time of catheter insertion, removal or as a late com-
plication [52, 53]. There is no consensus about the
treatment of retained fragments. Both conservative [52,
53] (Fig. 11) and surgical treatment [52, 54] are per-
formed. Nevertheless, serious complications like sub-
arachnoid haemorrhage [39, 55, 56] and migration into
the ventricle [56] are reported. Special attention must be
paid if an intrathecal fragment also remains partially
outside the spinal canal. Leakage of CSF with the de-
velopment of postural headache, a pseudomeningocele
[56] or even an intracranial hypotension syndrome could
occur. However, sometimes no CSF leakage is present
(Fig. 10). In a conservative approach, the position of the
retained catheter fragment should be followed-up over
time.
Step 14 Radio-opaque catheter tip
In the latest catheters, a titanium tip has been built
into the end of the catheter. In these intrathecal catheters,
on plain radiography this tip is recognised as a ball at the
end of the catheter (Figs. 2, 3 and 6).
Special pump roller examination
If the rotor of the pump stalls, a two-tone emergency
alarm will sound. After interrogation with the device pro-
grammer, the device display indicates a ‘Motor Stall’.
When no motor stall is indicated and this is not derived
from the pump logs, a roller study should be performed in
case failure is suspected (Fig. 12). In this procedure, the
pump is programmed in the continuous infusion mode,
using a preset, without activation and with a priming bo-
lus of 10 μl with a duration of 1 min. With fluoroscopy,
the rotor is visualised, thereby reducing the aperture. A
plain radiographic image is made and the preset bolus
delivery is activated. After 2 min, a new plain radiograph-
ic image is made and the two images are compared. In a
normal pump function, the rollers have moved approxi-
mately 60° from their original position. The extra radi-
opaque dot on one of the roller arms helps to visualise
the roller movement (Fig. 12).
Discussion
Although intrathecal drug administration using an im-
planted pump system has been employed for many years
in therapy-resistant spasticity and intractable pain, knowl-
edge on diagnostic imaging during adverse events remains
limited.
The main reasons for this limited knowledge include (1)
the diminished frequency of catheter-related treatment fail-
ures due to advancements in manufacturing and (2) the
limited application of the treatment in different clinics.
While plain radiography is the mainstay for the diagnosis
of drug delivery device-related adverse events, radiologists
play an important role in early diagnosis. An awareness of
typical radiographic images in relation to intrathecal cath-
e ter fa i lure is important to avoid a (somet imes
life-threatening) withdrawal syndrome. The most frequent
causes of drug delivery failure are migration, damage, dis-
connection and occlusion of the spinal catheter. In our
opinion, applying the presented 14-step analysis and in-
creasing the awareness of abnormal radiological findings
will help physicians to avoid a life-threatening withdrawal
syndrome.
A limitation of this proposal is that our approach has
not yet been validated but is based on our expert opinion.
Due to the present lack of high-quality evidence, we
strongly believe that, as a first step in quality improve-
ment, the current variation in radiological practice should
be avoided. The stepwise approach, as proposed by our
group, might be an effective first step towards raising the
quality of care related to troubleshooting for intrathecal
drug delivery with implanted systems.
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